Adjuvant rituximab, a potential treatment for the young patient with Graves’ hyperthyroidism (RiGD): study protocol for a single-arm, single-stage, phase II trial

INTRODUCTION: Graves’ disease (Graves’ hyperthyroidism) is a challenging condition for the young person and their family. The excess thyroid hormone generated by autoimmune stimulation of the thyroid stimulating hormone receptor on the thyroid gland can have a profound impact on well-being. Managing...

Descripción completa

Detalles Bibliográficos
Autores principales: Cole, Michael, Hynes, Ann Marie, Howel, Denise, Hall, Lesley, Abinun, Mario, Allahabadia, Amit, Barrett, Timothy, Boelaert, Kristien, Drake, Amanda J, Dimitri, Paul, Kirk, Jeremy, Zammitt, Nicola, Pearce, Simon, Cheetham, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347892/
https://www.ncbi.nlm.nih.gov/pubmed/30670519
http://dx.doi.org/10.1136/bmjopen-2018-024705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347892/
https://www.ncbi.nlm.nih.gov/pubmed/30670519
http://dx.doi.org/10.1136/bmjopen-2018-024705

Ejemplares similares